Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.
about
Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and TherapyDesign and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA).Novel tools for prostate cancer prognosis, diagnosis, and follow-upBioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cellsRetargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".GCPII imaging and cancer.PSMA expression by microvasculature of thyroid tumors - Potential implications for PSMA theranostics.Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: implications for novel intraoperative PSMA-based fluorescent imaging techniquesNext-generation cancer vaccine approaches: integrating lessons learned from current successes with promising biotechnologic advancesNKX3.1 as a marker of prostatic origin in metastatic tumors.Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer.T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression.Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA).Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.Cancer stratification by molecular imaging.Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapyUltrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging.Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerThe dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots.Expression, purification and identification of an immunogenic fragment in the ectodomain of prostate-specific membrane antigenTopology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade levelExosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Preclinical evaluation of a monoclonal antibody (3C6) specific for prostate-specific membrane antigenProstate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in miceComparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer.Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.Targeting the prostate-specific membrane antigen for prostate cancer therapy.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerPET imaging in prostate cancer: focus on prostate-specific membrane antigenThe prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.The clinical and therapeutic uses of MDM2 and PSMA and their potential interaction in aggressive cancers.Oncolytic virotherapy for urological cancers.Imaging of local recurrence in prostate cancer.Evaluation of a PSMA-targeted BNF nanoparticle construct.DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.
P2860
Q28080168-B8D5416B-29BB-4942-A84B-C9EE1A990475Q33586706-36E681E2-4D60-4622-8CAF-6E13582131F3Q33625338-6288A0CA-A25A-4150-A3B2-DF77233BDBE6Q33693099-14401AF8-FF92-4128-B732-D9D50184C8FFQ33761755-08475472-2811-460F-B85A-46FD074C01B3Q33827632-7859B36F-D15C-4174-B6A0-D09487871241Q33899288-FBC1A637-A1D1-4B59-A741-5624F7E2B5D6Q33922507-064FC5C7-1D40-4B0E-8CA4-0FC3D64B6BC1Q33973408-C29CB3DA-381E-4409-8444-DF71556A2D6FQ34123290-8BC92236-DCC0-4716-9CA9-C20290818274Q34292273-04221249-0F8C-462D-A20E-C2A49E8D8BE3Q34637387-612ED5DD-C6E1-4878-9E45-F199CA007BD7Q34893030-CFAB6809-C6C0-45D0-AA23-4124CF977AF5Q35282416-4B96C5C3-9B6A-4AE0-9E26-1BEEEB3550AEQ35348365-4C1E7C7D-6926-4EA3-85F0-E83AD9EAE59FQ35380664-F482BA8E-6276-4DF2-8B04-5CBB94F37385Q35605523-CF10EAAB-C014-4F39-8280-F45090E111F0Q35674555-98C31B9D-C79C-401B-BE7A-4EFA9DD9EC22Q35938051-CE56F2AE-F0B4-4220-BF0F-D7BD6746D084Q36415375-69697A38-1E03-4623-A38F-DB2305177A7AQ36422280-FC4B67F4-9126-4DA0-AFE5-E7B33F65D262Q36640007-DAD73FAB-BA4A-423E-BB55-984E0F82414CQ36926068-3B8A8BD4-8A7D-4C34-9002-3FC411E62EADQ37073022-E83B5AE0-F9D3-4DC5-83B4-DA8832CE4B3EQ37183709-344A9B71-6C0C-4F40-80BC-55A6DB0F52A6Q37371051-B71ED68D-55B4-43B2-B2DB-F0C7CF9B7772Q37541876-01DE02AE-CD5E-46E7-9E8C-2C042D36C3FEQ37554230-C0D53BB2-C9B3-4474-8793-141B88EFDE7CQ37633545-90A7CE6C-35F9-4CB2-8590-F329A2151BEEQ37714940-D0A0E98F-C189-4926-8159-D351113D1AC0Q37773273-D8D175EC-837D-497F-8D6B-1F152FA86C2CQ37972920-0C6B34B2-B93A-4F83-93B5-4A508D95B309Q38099369-35010400-4D5C-462B-86C1-62771BC12215Q38169828-3A3A04AE-1589-4A49-9A54-6CC190468CF4Q38391360-6F18BB65-D93B-4B42-91A3-69AA699CB25BQ38637803-FA055B9C-384C-4F22-B949-57CB97E5A8CEQ38842126-6F7702E4-BA2A-42F2-9D86-0F4864C7B09DQ38852724-1A03604D-348E-4F26-B34C-13F91B95A55EQ38910401-7C18F0A7-0D9F-4BFD-BA5F-E0F8498DEAA4Q39538214-4D8DCB27-2FC5-4C6A-8563-D698D00FD631
P2860
Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Prostate-specific membrane ant ...... r tissue microarray technique.
@en
type
label
Prostate-specific membrane ant ...... r tissue microarray technique.
@en
prefLabel
Prostate-specific membrane ant ...... r tissue microarray technique.
@en
P2093
P2860
P1433
P1476
Prostate-specific membrane ant ...... r tissue microarray technique.
@en
P2093
Chadhuri A
Mhawech-Fauceglia P
Penetrante R
Terracciano L
P2860
P304
P356
10.1111/J.1365-2559.2007.02635.X
P577
2007-03-01T00:00:00Z